| scholarly article | Q13442814 |
| P2093 | author name string | Chang-Keun Kim | |
| Yong Ju Lee | |||
| P2860 | cites work | The impact of asthma and its treatment on growth: an evidence-based review | Q93345635 |
| Biomarkers for Recurrent Wheezing and Asthma in Preschool Children | Q93385050 | ||
| Allergic Rhinitis in Rats Is Associated with an Inflammatory Response of the Hippocampus. | Q55349788 | ||
| Montelukast Reduces Serum Levels of Eosinophil-Derived Neurotoxin in Preschool Asthma | Q57279740 | ||
| A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis | Q57534680 | ||
| SRS-A leukotrienes decrease the activity of human respiratory cilia | Q57638504 | ||
| Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review | Q58611857 | ||
| Leukotrienes are potent constrictors of human bronchi | Q59082833 | ||
| Pediatric asthma treatment: What to do when international guideline recommendations do not agree | Q64138107 | ||
| Prescription Patterns and Burden of Pediatric Asthma in Korea | Q64228065 | ||
| The effect of inhaled leukotriene D4 in humans | Q69885398 | ||
| Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro | Q70469921 | ||
| Cysteinyl leukotriene receptors | Q78517576 | ||
| Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity | Q84437068 | ||
| Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort | Q90014138 | ||
| Treatment with montelukast and antidepressive medication-a symmetry analysis | Q91095290 | ||
| Multicenter Adherence Study of Asthma Medication for Children in Korea | Q91127349 | ||
| Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-Control Study | Q92578615 | ||
| Characterization of the human cysteinyl leukotriene CysLT1 receptor | Q22010199 | ||
| Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children | Q24186483 | ||
| Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children | Q24197682 | ||
| Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response | Q24634918 | ||
| Characterization of within-subject responses to fluticasone and montelukast in childhood asthma | Q28306277 | ||
| A meta-analysis of montelukast for recurrent wheeze in preschool children | Q33840794 | ||
| Leukotriene C: a slow-reacting substance from murine mastocytoma cells | Q33972104 | ||
| Liberation of histamine and formation of lysocithin-like substances by cobra venom | Q34568156 | ||
| Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing | Q35015651 | ||
| Leukotrienes and airway inflammation | Q35106124 | ||
| Tucson Children's Respiratory Study: 1980 to present | Q35110736 | ||
| The role of leukotrienes in nasal allergy | Q35213121 | ||
| Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. | Q37021420 | ||
| Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. | Q37283122 | ||
| Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions | Q37486326 | ||
| Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4 | Q37606896 | ||
| Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors | Q37955161 | ||
| Montelukast-induced adverse drug reactions: a review of case reports in the literature | Q38246667 | ||
| The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. | Q38458030 | ||
| Leukotriene receptor antagonists as maintenance or intermittent treatment in pre-school children with episodic viral wheeze. | Q38656184 | ||
| Classification and pharmacological treatment of preschool wheezing: changes since 2008. | Q39251012 | ||
| Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase(®). | Q40260443 | ||
| Cysteinyl leukotrienes in asthma: old mediators up to new tricks | Q40372475 | ||
| Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma | Q42007128 | ||
| Adverse drug reactions of montelukast in children and adults | Q42253966 | ||
| A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation | Q43155864 | ||
| Early control treatment with montelukast in preschool children with asthma: A randomized controlled trial | Q47368982 | ||
| Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma | Q47763868 | ||
| The Association Between Leukotriene-Modifying Agents and Suicidality: A Review of Literature | Q47766986 | ||
| Neuropsychiatric Events Associated with Leukotriene-Modifying Agents: A Systematic Review. | Q50093929 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P577 | publication date | 2020-02-05 | |
| P1476 | title | Review of montelukast use over the past 20 years and monitoring of its effects |
Search more.